<p>This is a $199,969 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Accelerated Medical Diagnostics, Inc. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type with a completion date of September 30, 2016. As an SBIR Phase I award, this contract supports early-stage research and development activities.</p>
This is a $182,050 firm fixed price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanoivd, Inc., a small disadvantaged, woman-owned business. The contract is for TAS::75 0849::TAS and has a total small business set-aside designation. The period of performance runs from the award date of September 30, 2010 through the ultimate completion date of March 30, 2011. Nanoivd, Inc. is the prime contractor, and no subcontractors are mentioned. The contract...
<p>This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Radiation Management Associates, LLC, a small business. The contract is for other functions radiation support and related services, with a period of performance ending on December 31, 2007. The contract has a ceiling value of $145,441,264.00 and utilizes a cost-plus-fixed-fee pricing type. The place of performance is Greenbelt, MD. This contract is a set-aside for small businesses.</p>
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Cureline Inc., a woman-owned small business. The contract is for the procurement of breast ductal, colon, head and neck, lung adenocarcinoma, lung squamous, kidney renal, stomach, uterine corpus, and melanoma tissue samples under the NCI Cancer Genome Atlas Program Tissue Purchase contract vehicle. The contract has a ceiling value of $212,610.63 and a completion date of January 24,...
This is a firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Digital Artefacts LLC, a minority-owned, small disadvantaged business. The contract is for the development of a "CANCER PATIENT COGNITIVE ASSESSMENT PLATFORM" under TOPIC 343, with a ceiling value of $216,431.00 and a completion date of September 18, 2017. The contract does not have a set-aside designation. As the NCI is the funding agency, this contract supports the...
This is a $98,100.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Asterand US Acquisition Corporation, a for-profit organization. The contract is under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract vehicle and is set aside for small businesses. The purpose of the contract is to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. The ultimate completion date for the contract is August...
This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....
<p>This is a Firm Fixed Price Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Intaset Technologies Corporation, a small business contractor. The contract is for long-term administrative support services for the NCI Division of Cancer Treatment and Diagnosis, with a ceiling value of $350,505.99 and an ultimate completion date of March 5, 2013. The contract was set aside for total small business participation.</p>
This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian federal agency, to Ilsbio LLC, a for-profit limited liability company. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. This award is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and is funded under the American Recovery and Reinvestment Act (ARRA). The contract has a...
<p>This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nano Terra, Inc., a self-certified small disadvantaged business, for administrative support services. The contract has a total ceiling value of $299,948.00 and is a firm fixed-price contract. The period of performance ends on October 19, 2014. The contract is set aside for small businesses.</p>